Skip to main content
OpenTrials

Clinical trial condition

Wet Macular Degeneration

Explore clinical trials studying Wet Macular Degeneration. Study availability and eligibility vary by location and protocol.

77 public trials 8 recruiting studies
Refine in advanced search Browse all conditions

Wet Macular Degeneration trial results

Active, not recruiting

A Masked, Placebo-controlled Study to Assess Iptacopan in Age-related Macular Degeneration

NCT05230537

Conditions
Age-Related Macular Degeneration, Eye Diseases, Geographic Atrophy, +10 more
Locations
  • Retina Consultants of Orange County Fullerton, California, United States
  • Salehi Retina Institute Huntington Beach, California, United States
  • Martel Eye Medical Group Rancho Cordova, California, United States
  • Retinal Consultants Medical Group Inc Sacramento, California, United States
View all 28 locations
View Trial Details
Active, not recruiting

NG101 AAV Gene Therapy in Subjects With Wet Age-Related Macular Degeneration

NCT05984927

Conditions
Age-Related Macular Degeneration, Choroid Diseases, Choroidal Neovascularization, +11 more
Locations
  • Cincinnati Eye Institute Cincinnati, Ohio, United States
  • Vancouver Coastal Health Research Institute Vancouver, British Columbia, Canada
  • Sunnybrook Ophthalmology and Vision Services Toronto, Ontario, Canada
  • Vitreous Retina Macula Specialists of Toronto Toronto, Ontario, Canada
View Trial Details
Active, not recruiting

Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD

NCT05407636

Conditions
AMD, CNV, Choroid Diseases, +16 more
Locations
  • Barnet Dulaney Eye Center-Phoenix /ID# 256340 Phoenix, Arizona, United States
  • Retinal Research Institute /ID# 256238 Phoenix, Arizona, United States
  • Retina Macula Institute of Arizona /ID# 271026 Scottsdale, Arizona, United States
  • California Retina Consultants - Bakersfield /ID# 256240 Bakersfield, California, United States
View all 181 locations
View Trial Details
Active, not recruiting

4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration

NCT06864988

Conditions
Eye Diseases, Macular Degeneration, Macular Neovascularization Secondary to Age-Related Macular Degeneration, +3 more
Locations
  • Barnet Dulaney Perkins Eye Center Phoenix, Arizona, United States
  • Retinal Research Institute, LLC Scottsdale, Arizona, United States
  • Retina Partners of Northwest Arkansas Springdale, Arkansas, United States
  • California Retina Consultants Bakersfield, California, United States
View all 95 locations
View Trial Details
Active, not recruiting

Pivotal 1 Study of ABBV-RGX-314 (Also Known as RGX-314) Gene Therapy Administered Via Subretinal Delivery One Time in Participants With nAMD

NCT04704921

Conditions
AMD, CNV, Choroid Diseases, +18 more
Locations
  • Retinal Research Institute /ID# 256019 Phoenix, Arizona, United States
  • Barnet Dulaney Perkins Eye Center - Sun City /ID# 256055 Sun City, Arizona, United States
  • University of Arkansas for Medical Sciences /ID# 271290 Little Rock, Arkansas, United States
  • Retina Vitreous Assoc Med Grp /ID# 256299 Beverly Hills, California, United States
View all 89 locations
View Trial Details
Active, not recruiting

Long-term Study of ADVM-022 in Neovascular (Wet) AMD [OPTIC-EXT]

NCT04645212

Conditions
Blindness, Choroid Diseases, Choroidal Neovascularization, +18 more
Locations
  • Adverum Clinical Site Bakersfield, California, United States
  • Adverum Clinical Site Beverly Hills, California, United States
  • Adverum Clinical Site Lakewood, Colorado, United States
  • Adverum Clinical Site Deerfield Beach, Florida, United States
View Trial Details
Active, not recruiting

Safety and Efficacy of ADVM-022 in Treatment-Experienced Patients With Neovascular Age-related Macular Degeneration [LUNA]

NCT05536973

Conditions
Blindness, Choroid Diseases, Choroidal Neovascularization, +16 more
Locations
  • Adverum Clinical Site 178 Phoenix, Arizona, United States
  • Adverum Clinical Site 126 Phoenix, Arizona, United States
  • Adverum Clinical Site 159 Tucson, Arizona, United States
  • Adverum Clinical Site 100 Beverly Hills, California, United States
View all 39 locations
View Trial Details
Completed

A Clinical Effectiveness Study Examining the Efficacy and Safety of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD)

NCT03834753

Conditions
Age-Related Macular Degeneration, Eye Diseases, Macular Degeneration, +4 more
Locations
  • Clinical Site Tucson, Arizona, United States
  • Clinical Site Arcadia, California, United States
  • Clinical Site Beverly Hills, California, United States
  • Clinical Site Campbell, California, United States
View all 50 locations
View Trial Details

Related conditions